Subunit influenza virus vaccine Grippovac SE-AZh (vaccination of adults).
Grippovac SE-AZh a polytype, subunit influenza virus vaccine containing H1N1 and H3N2 influenza A virus strains and one influenza B virus strain has been tested in 80 volunteers. The trials demonstrated the harmlessness, the absence of adverse reactions, and except of the B type, the high antigenicity of vaccine preparation when administered in two injections. The optimal dose of each viral strain haemagglutinin (HA) was 15 micrograms in 0.5 ml.
Rudenko
L G
LG
Zykov
M P
MP
Romanov YuA
Zakharov
N G
NG
Leonov
V M
VM
Melnikova
S K
SK
Chumakov
M P
MP
D000328:Adult; D000956:Antigens, Viral / Q000032:analysis; D005334:Fever / Q000209:etiology; D006801:Humans; D007109:Immunity; D009980:Influenza A virus / Q000276:immunology; D009981:Influenza B virus / Q000276:immunology; D007252:Influenza Vaccines / Q000009:adverse effects / Q000276:immunology*; D014611:Vaccination
D000956:Antigens, Viral; D007252:Influenza Vaccines